- £62.33m
- £74.52m
- £89.14m
- 65
- 86
- 81
- 92
2019 June 30th | 2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 90.1 | 76 | 77.8 | 89.4 | 89.1 |
Cost of Revenue | |||||
Gross Profit | 26.8 | 22.6 | 29.4 | 33.4 | 32.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 88.8 | 73.1 | 67.8 | 76.7 | 77.7 |
Operating Profit | 1.27 | 2.85 | 9.96 | 12.6 | 11.5 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 0.985 | 2.36 | 9.47 | 12 | 10.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.729 | 1.92 | 7.35 | 9.61 | 8.35 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3.64 | 2.26 | 7.59 | -7.05 | 6.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 3.64 | 2.26 | 7.59 | -7.05 | 6.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.166 | 0.073 | 0.21 | 0.286 | 0.248 |
Dividends per Share |